Financial reports
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
15 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
30 Mar 22
Current reports
8-K
Regulation FD Disclosure
9 Feb 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Regulation FD Disclosure
11 Dec 23
8-K
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
13 Nov 23
8-K
Regulation FD Disclosure
25 Oct 23
8-K
ORX750, an oral selective orexin receptor 2 agonist, promotes wakefulness and reduces cataplexy in the orexin/ataxin-3 mouse
23 Aug 23
8-K
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
14 Aug 23
8-K
Regulation FD Disclosure
10 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
22 Jun 23
8-K
Regulation FD Disclosure
9 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
30 Mar 23
424B5
Prospectus supplement for primary offering
27 Jan 23
S-3
Shelf registration
1 Jul 22
S-8
Registration of securities for employees
1 Jul 22
S-8
Registration of securities for employees
11 Jun 21
424B4
Prospectus supplement with pricing info
1 Jun 21
S-1MEF
Registration of additional securities for an S-1
27 May 21
S-1/A
IPO registration (amended)
26 May 21
8-A12B
Registration of securities on exchange
25 May 21
S-1/A
IPO registration (amended)
24 May 21
Other
EFFECT
Notice of effectiveness
13 Jul 22
EFFECT
Notice of effectiveness
28 May 21
EFFECT
Notice of effectiveness
28 May 21
CERT
Certification of approval for exchange listing
27 May 21
SEC STAFF
SEC staff action: Order
27 May 21
CORRESP
Correspondence with SEC
26 May 21
CORRESP
Correspondence with SEC
25 May 21
CORRESP
Correspondence with SEC
25 May 21
UPLOAD
Letter from SEC
25 May 21
CORRESP
Correspondence with SEC
20 May 21
Ownership
4
Karen M. Anderson
26 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 24
4
DAVID M CHAO
2 Feb 24
4
IQBAL J HUSSAIN
2 Feb 24
4
Gregory M Weinhoff
2 Feb 24
4
SAURABH SAHA
2 Feb 24
4
Tia L Bush
2 Feb 24
4
Harris Rotman
2 Feb 24